Overview

Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia

Status:
COMPLETED

Trial end date:
2024-04-10

Target enrollment:

Participant gender:

Summary

Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Chinese Healthy Adult Subjects with Presbyopia

Phase:

PHASE1

Details

Lead Sponsor:

Corxel Pharmaceuticals

Collaborator:

LENZ Therapeutics, Inc

Treatments:

aceclidine
Brimonidine Tartrate
Ophthalmic Solutions